The NOGO receptor NgR2, a novel αVβ3 integrin effector, induces neuroendocrine differentiation in prostate cancer.
Quaglia F, Krishn SR, Sossey-Alaoui K, Rana PS, Pluskota E, Park PH, Shields CD, Lin S, McCue P, Kossenkov AV, Wang Y, Goodrich DW, Ku SY, Beltran H, Kelly WK, Corey E, Klose M, Bandtlow C, Liu Q, Altieri DC, Plow EF, Languino LR.
Quaglia F, et al. Among authors: sossey alaoui k.
Sci Rep. 2022 Nov 7;12(1):18879. doi: 10.1038/s41598-022-21711-5.
Sci Rep. 2022.
PMID: 36344556
Free PMC article.